PERRY C, SOOMRO I, KAYE P, HARDY E, PARSONS SL, RAGUNATH K, LOBO DN, MARTIN SG and MADHUSUDAN S, 2015. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus / I.S.D.E. 28(3), 262-268
ELEFTHERIOU M, PASCUAL AJ, WHELDON LM, PERRY C, ABAKIR A, ARORA A, JOHNSON AD, AUER DT, ELLIS IO, MADHUSUDAN S and RUZOV A, 2015. Clinical epigenetics. 7(1), 88
ALBARAKATI, NADA, ABDEL-FATAH, TAREK M. A., DOHERTY, RACHEL, RUSSELL, ROSLIN, AGARWAL, DEVIKA, MOSELEY, PAUL, PERRY, CHRISTINA, ARORA, ARVIND, ALSUBHI, NOUF, SEEDHOUSE, CLAIRE, RAKHA, EMAD A., GREEN, ANDREW, BALL, GRAHAM, CHAN, STEPHEN, CALDAS, CARLOS, ELLIS, IAN O. and MADHUSUDAN, SRINIVASAN, 2015. MOLECULAR ONCOLOGY. 9(1), 204-217
ABDEL-FATAH TM, ARORA A, MOSELEY PM, PERRY C, RAKHA EA, GREEN AR, CHAN SY, ELLIS IO and MADHUSUDAN S, 2015. Oncotarget. 6(26), 21964-78
ROBERTSON E, PERRY C, DOHERTY R and MADHUSUDAN S, 2015. Transcriptomic profiling of Forkhead Box transcription factors in adult glioblastoma multiforme. Cancer Genomics and Proteomics. 12(3), 103-112
ABDEL-FATAH TMA, MIDDLETON FK, ARORA A, AGARWAL D, CHEN T, MOSELEY P, PERRY C, DOHERTY R, CHAN S, GREEN A, RAKHA E, BALL G, ELLIS IO, CURTIN N and MADHUSUDAN S, 2015. Untangling the ATR-Chk1 network for prognostication, prediction and therapeutic target validation in breast cancer. Molecular Oncology. 9(3), 569-85
ABDEL-FATAH TMA, RUSSELL R, AGARWAL D, MOSELEY P, ABAYOMI MA, PERRY C, ALBARAKATI N, BALL G, CHAN S, CALDAS C, ELLIS IO and MADHUSUDAN S, 2014. Molecular oncology. 8(3), 520-32
ABDEL-FATAH TMA, PERRY C, MOSELEY P, JOHNSON K, ARORA A, CHAN S, ELLIS IO and MADHUSUDAN S, 2014. Breast cancer research and treatment. 143(3), 411-21
ABDEL-FATAH TM, PERRY C, ARORA A, THOMPSON N, DOHERTY R, MOSELEY PM, GREEN AR, CHAN SY, ELLIS IO and MADHUSUDAN S, 2014. Antioxidants & redox signaling. 21(16), 2262-8
ABDEL-FATAH T, ARORA A, AGARWAL D, MOSELEY P, PERRY C, THOMPSON N, GREEN AR, RAKHA E, CHAN S, BALL G, ELLIS IO and MADHUSUDAN S, 2014. Breast cancer research and treatment. 146(2), 309-20
ABDEL-FATAH TMA, ARORA A, ALSUBHI N, AGARWAL D, MOSELEY PM, PERRY C, DOHERTY R, CHAN SYT, GREEN AR, RAKHA E, BALL G, ELLIS IO and MADHUSUDAN S, 2014. Neoplasia (New York, N.Y.). 16(11), 982-91
PERRY C, AGARWAL D, ABDEL-FATAH TMA, LOURDUSAMY A, GRUNDY R, AUER DT, WALKER D, WALKER D, LAKHANI R, SCOTT IS, CHAN S, BALL G and MADHUSUDAN S, 2014. Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era. Oncotarget. 5(14), 5764-5781
LANGMACK KA, PERRY C, SINSTEAD C, MILLS J and SAUNDERS D, 2014. The Utility of atlas-assisted segmentation in the male pelvis is dependent on the interobserver agreement of the structures segmented. British Journal of Radiology. 87(1043), 20140299
ABDEL-FATAH TMA, ARORA A, MOSELEY P, COVENEY C, PERRY C, JOHNSON K, KENT C, HAMMED K, BALL G and CHAN S, 2014. Ataxia-telangiectasia mutated (ATM), ataxia-telangiectasia mutated and Rad3 related kinase (ATR) and DNA-dependent protein kinase (DNA-PK) expression correlate to adverse clinical outcomes in human epithelial ovarian cancers. BAA Clinical. 2, 10-17
SULTANA R, ABDEL-FATAH T, PERRY C, MOSELEY P, ALBARAKTI N, MOHAN V, SEEDHOUSE C, CHAN S and MADHUSUDAN S, 2013. PloS one. 8(2), e57098
ABDEL-FATAH TMA, PERRY C, DICKINSON P, BALL G, MOSELEY P, GREEN A, MADHUSUDAN S, ELLIS I and CHAN S, 2013. Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to Anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings. Annals of Oncology. 24(11), 2801-2807
PERRY C and SUNDAR S, 2012. Cabazitaxel rechallenge at prostate-specific antigen relapse after previous cabazitaxel and docetaxel chemotherapy: Case Report. Clinical Genitourinary Cancer. 10(3), 207-209
GOSSAGE L, PERRY C and MADHUSUDAN S, 2012. Base excision repair factors are promising prognostic and predictive factors in cancer. Current Molecular Pharmacology. 5, 115-124
MURALI-GANESH, R., MALHOTRA, R., PERRY, C.J. and MADHUSUDAN, S., 2011. Human Apurinic/Apyrimidinic Endonuclease (APE1): An Emerging Anti-Cancer Biomarker. Recent Patents On Biomarkers. 1(2), 150-158
PERRY, C, SULTANA, R and MADHUSUDAN S, 2011. Personalized Cancer Medicine: DNA Repair Alterations Are Promising Predictive Biomarkers in Cancer. In: KELLEY, M.R., ed., DNA Repair in Cancer Therapy Elsevier. 257-282
ABBOTTS R, PERRY C and MADHUSUDAN S, 2011. Human apurinic/apyrimidinic endonuclease is a novel drug target in cancer. In: VENGROVA S, ed., DNA repair and Human Health In Tech.
PERRY C, BLUNDELL A and SEDDON D, 2008. An unusual cause of spinal cord compression Acute Medicine. 7(2), 89-90